Methods for the screening and/or for the identification of differentially active nucleic acid binding factors of nucleic acid binding elements using dna microarray technology (dpa):dna proteomic array
CA 2327561 A1 · Owner: Camato, Rino N. · Inventors: Camato, Rino N.; Rousseau, Pierre; Larose, Anne-Marie
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides a method for the screening and for the identification of nucleic acid binding factor, or nucleic acid binding elements that are differentially active between same cells with different treatments, or two phenotypically different cells (normal and modified cells). The invention provides methods for, identifying compounds that modulate the DNA binding activity of nucleic acid binding factors, compounds, that are nucleic acid binding factor analogs and compounds that selectively bind cis acting nucleic acid in, any type of cells or tissues.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 27, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 27, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 27, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.